America’s fentanyl crisis is showing its first major signs of retreat, but the battle is far from over.
On April 15, the CDC released provisional data projecting just 70,231 drug overdose deaths for the 12-month period ending November 2025 — a more than 15% decline from the previous year and the largest drop since the fentanyl epidemic began.
Yet even as deaths fall, fentanyl remains the leading killer of Americans aged 18 to 45, while the drug trade continues to evolve with deadlier synthetics and sophisticated global supply chains that keep the crisis dangerously alive.
DEA Scores Historic Win: 57 Million Deadly Fentanyl Doses Seized
Just days before National Fentanyl Awareness Day on April 29, the DEA released results from its “Phase II” of “Operation Fentanyl Free America.” In just one month – between January 12 and February 10 – agents seized more than 4.7 million fentanyl pills and nearly 2,400 pounds of powder, enough for an estimated 57 million potentially lethal doses taken off the streets.
That effort was part of a nationwide crackdown that also led to the seizure of 147,000 pounds of cocaine, 21,000 pounds of methamphetamine, and more than 1,500 guns.
“The drug poisoning epidemic has been cultivated by designated terrorist cartels who operate like multi-billion-dollar corporations and have weaponized fentanyl with the clear objective to increase America’s dependence on illicit drugs,” DEA Administrator Terrance Cole said in a statement after the historic bust.
DEA lab testing found that 29% of fentanyl pills analyzed in fiscal year 2025 contained a potentially lethal dose – a big decline from 76% in fiscal year 2023, according to the agency.
Fentanyl Precursors Classified as Weapons of Mass Destruction
On April 23, the U.S. State Department announced targeted economic sanctions against a transnational criminal network that has been supplying fentanyl precursor chemicals to the Sinaloa Cartel. According to the department, the crime networks mainly operate across India, Guatemala, and Mexico. The sanctions were issued under Executive Order 14367, which even classifies fentanyl and its key precursor chemicals as Weapons of Mass Destruction.
India’s growing role as a supplier of fentanyl precursor chemicals has quietly flown under Washington’s radar – and now the State Department warns that this blind spot could undermine drug enforcement efforts in Mexico and at the Southern Border.
Enforcement Up, Treatment Down
At the same time that fentanyl enforcement is ramping up across America, treatment programs are being strained.
The Trump administration has reduced staffing at the Substance Abuse and Mental Health Services Administration by roughly half, and an estimated $1.7 billion in block grants for state health departments – along with approximately $350 million in addiction and overdose prevention funding – has been cut, per STAT News.
Next Generation Killer Drugs
Even as fentanyl deaths decline, a newer and in some ways more alarming threat is spreading through America’s drug supply – modern synthetic opioids and tranquilizers.
As The Dallas Express has previously covered, over the past few years, Xylazine – a veterinary tranquilizer known on the street as “tranq” – has been found mixed with fentanyl in 48 of 50 states.
Unlike Fentanyl, Xylazine does not respond to naloxone, the standard overdose reversal medication, making it especially deadly for first responders to treat. The DEA has described Xylazine as making “the deadliest drug threat our country has ever faced, fentanyl, even deadlier.”
An emerging class of synthetic opioids is joining Xylazine – including nitazenes and cychlorphine – that are reported to be even more potent than fentanyl itself and similarly resistant to standard overdose treatments.
Public health officials report that these substances are increasingly appearing in street drug supplies, with users often unaware of what they are taking, creating unpredictable and potentially untreatable overdose scenarios across the country, per the CDC.
